BFRI
Price
$0.84
Change
-$0.00 (-0.00%)
Updated
Sep 5 closing price
Capitalization
9.01M
KMDA
Price
$7.14
Change
+$0.08 (+1.13%)
Updated
Sep 5 closing price
Capitalization
401.71M
65 days until earnings call
Interact to see
Advertisement

BFRI vs KMDA

Header iconBFRI vs KMDA Comparison
Open Charts BFRI vs KMDABanner chart's image
Biofrontera
Price$0.84
Change-$0.00 (-0.00%)
Volume$77.52K
Capitalization9.01M
Kamada
Price$7.14
Change+$0.08 (+1.13%)
Volume$129.8K
Capitalization401.71M
BFRI vs KMDA Comparison Chart in %
Loading...
BFRI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
KMDA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
BFRI vs. KMDA commentary
Sep 08, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BFRI is a Hold and KMDA is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 08, 2025
Stock price -- (BFRI: $0.84 vs. KMDA: $7.14)
Brand notoriety: BFRI and KMDA are both not notable
Both companies represent the Pharmaceuticals: Generic industry
Current volume relative to the 65-day Moving Average: BFRI: 32% vs. KMDA: 257%
Market capitalization -- BFRI: $9.01M vs. KMDA: $401.71M
BFRI [@Pharmaceuticals: Generic] is valued at $9.01M. KMDA’s [@Pharmaceuticals: Generic] market capitalization is $401.71M. The market cap for tickers in the [@Pharmaceuticals: Generic] industry ranges from $67.95B to $0. The average market capitalization across the [@Pharmaceuticals: Generic] industry is $3.92B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BFRI’s FA Score shows that 1 FA rating(s) are green whileKMDA’s FA Score has 0 green FA rating(s).

  • BFRI’s FA Score: 1 green, 4 red.
  • KMDA’s FA Score: 0 green, 5 red.
According to our system of comparison, both BFRI and KMDA are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BFRI’s TA Score shows that 3 TA indicator(s) are bullish while KMDA’s TA Score has 6 bullish TA indicator(s).

  • BFRI’s TA Score: 3 bullish, 7 bearish.
  • KMDA’s TA Score: 6 bullish, 4 bearish.
According to our system of comparison, KMDA is a better buy in the short-term than BFRI.

Price Growth

BFRI (@Pharmaceuticals: Generic) experienced а -4.72% price change this week, while KMDA (@Pharmaceuticals: Generic) price change was +3.18% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Generic industry was +0.08%. For the same industry, the average monthly price growth was +12.00%, and the average quarterly price growth was +86.48%.

Reported Earning Dates

KMDA is expected to report earnings on Nov 12, 2025.

Industries' Descriptions

@Pharmaceuticals: Generic (+0.08% weekly)

A generic drug contains the same chemical substance as a drug that was originally protected by patents. Generic drugs are generally sold at cheaper price points, compared to name-brand pharmaceuticals, after patents for the more expensive drugs lapse. The generic drug industry has created a major market, thanks to the lower pricing. According to the Center for Justice and Democracy at New York Law School, 80 percent of all drugs prescribed are generic, and generic drugs are chosen 94 percent of the time when they are available. But their manufacturers must be able to prove to the FDA that they can be effective substitutes for the original drugs. Some of the major generic drug makers include Zoetis, Inc., Allergan plc and Mylan N.V.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
KMDA($402M) has a higher market cap than BFRI($9.01M). KMDA has higher P/E ratio than BFRI: KMDA (22.31) vs BFRI (0.89). KMDA YTD gains are higher at: 20.601 vs. BFRI (-22.541). KMDA has higher annual earnings (EBITDA): 34.2M vs. BFRI (-15.28M). KMDA has more cash in the bank: 66M vs. BFRI (7.25M). BFRI has less debt than KMDA: BFRI (5M) vs KMDA (11.4M). KMDA has higher revenues than BFRI: KMDA (170M) vs BFRI (39.2M).
BFRIKMDABFRI / KMDA
Capitalization9.01M402M2%
EBITDA-15.28M34.2M-45%
Gain YTD-22.54120.601-109%
P/E Ratio0.8922.314%
Revenue39.2M170M23%
Total Cash7.25M66M11%
Total Debt5M11.4M44%
FUNDAMENTALS RATINGS
KMDA: Fundamental Ratings
KMDA
OUTLOOK RATING
1..100
11
VALUATION
overvalued / fair valued / undervalued
1..100
71
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
78
PRICE GROWTH RATING
1..100
52
P/E GROWTH RATING
1..100
37
SEASONALITY SCORE
1..100
75

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
BFRIKMDA
RSI
ODDS (%)
Bearish Trend 5 days ago
90%
Bullish Trend 3 days ago
60%
Stochastic
ODDS (%)
Bullish Trend 3 days ago
90%
Bullish Trend 3 days ago
60%
Momentum
ODDS (%)
Bearish Trend 3 days ago
90%
Bullish Trend 3 days ago
59%
MACD
ODDS (%)
Bearish Trend 3 days ago
90%
Bullish Trend 3 days ago
67%
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
90%
Bullish Trend 3 days ago
63%
TrendMonth
ODDS (%)
Bearish Trend 3 days ago
90%
Bullish Trend 3 days ago
69%
Advances
ODDS (%)
Bullish Trend 25 days ago
79%
Bullish Trend 3 days ago
65%
Declines
ODDS (%)
Bearish Trend 11 days ago
90%
Bearish Trend 10 days ago
66%
BollingerBands
ODDS (%)
Bullish Trend 3 days ago
84%
Bullish Trend 3 days ago
60%
Aroon
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
58%
View a ticker or compare two or three
Interact to see
Advertisement
BFRI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
KMDA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ANAB21.900.81
+3.84%
AnaptysBio
PAGS9.600.34
+3.67%
PagSeguro Digital Ltd
BLNK1.02N/A
N/A
Blink Charging Co
BURL291.20-10.15
-3.37%
Burlington Stores
KZIA7.76-0.33
-4.08%
Kazia Therapeutics Limited

BFRI and

Correlation & Price change

A.I.dvisor tells us that BFRI and RDHL have been poorly correlated (+23% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that BFRI and RDHL's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BFRI
1D Price
Change %
BFRI100%
+0.64%
RDHL - BFRI
23%
Poorly correlated
+16.54%
COLL - BFRI
21%
Poorly correlated
-2.32%
TLRY - BFRI
21%
Poorly correlated
+3.48%
CRON - BFRI
20%
Poorly correlated
N/A
KMDA - BFRI
20%
Poorly correlated
+1.13%
More

KMDA and

Correlation & Price change

A.I.dvisor tells us that KMDA and SIGA have been poorly correlated (+32% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that KMDA and SIGA's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To KMDA
1D Price
Change %
KMDA100%
+1.13%
SIGA - KMDA
32%
Poorly correlated
-0.82%
OGI - KMDA
26%
Poorly correlated
+2.48%
RDY - KMDA
24%
Poorly correlated
+1.34%
SCYX - KMDA
23%
Poorly correlated
+2.43%
EBS - KMDA
23%
Poorly correlated
-0.66%
More